{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/luts-in-men/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"8874a841-31e1-5356-a3f6-7bff9c28c693","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field 74abc0bf-eabc-4b3d-8480-5a7b853cdb79 --><h2>How should I assess a man with lower urinary tract symptoms?</h2><!-- end field 74abc0bf-eabc-4b3d-8480-5a7b853cdb79 -->","summary":"","htmlStringContent":"<!-- begin item 4e974f82-5fe9-4cab-a9a5-cbd242eb0c13 --><!-- begin field 28880ac5-33cb-4d1d-9c5c-657caf3fa676 --><ul><li><strong>Take a history.</strong><ul><li>Establish the type (or combination of types) of lower urinary tract symptoms (LUTS) the man has by asking about:<ul><li>Storage symptoms, including urgency, daytime urinary frequency, nocturia, urinary incontinence, and feeling the need to urinate again just after passing urine. Specifically ask about bedwetting, as this can be a sign of chronic urinary retention.</li><li>Voiding symptoms, including hesitancy, weak or intermittent urinary stream sometimes causing splitting or spraying, straining, intermittency, incomplete emptying, and terminal dribbling.</li><li>Post-micturition symptoms, including post-micturition dribble and the sensation of incomplete emptying.</li></ul></li><li>Ask about possible underlying <a class=\"topic-reference internal-reference\" href=\"/topics/luts-in-men/background-information/causes-of-luts/\">causes</a> of the specific type of LUTS, including comorbidities (such as diabetes and multiple sclerosis) and current drug treatments (including herbal and over-the-counter medicines).</li><li>Establish the man's main concerns, for example whether he is worried about cancer, symptom progression, or acute urinary retention.</li></ul></li><li><strong>Examine the man to assess for the underlying <a class=\"topic-reference internal-reference\" href=\"/topics/luts-in-men/background-information/causes-of-luts/\">cause</a> of the specific type of LUTS.</strong><ul><li>Examine the abdomen for signs of a distended bladder, such as abdominal distention and suprapubic dullness on percussion.</li><li>Check the external genitalia to identify conditions that may cause or contribute to LUTS, for example phimosis, meatal stenosis, or penile cancer.</li><li>Perform a digital rectal examination to assess the prostate for size, consistency, nodules, and tenderness.</li><li>Examine the perineum and/or lower limbs to evaluate motor and sensory function.</li></ul></li><li><strong>Ask men with bothersome LUTS to complete a <a class=\"topic-reference internal-reference\" href=\"/topics/luts-in-men/diagnosis/assessment/#urinary-frequency-volume-chart\">urinary frequency-volume chart</a> for at least 3 days, </strong>to distinguish between urinary frequency, polyuria, nocturia, and nocturnal polyuria.</li><li><strong>Exclude serious causes of LUTS, including:</strong><ul><li>Urological cancer — may present with a prostate that is hard and irregular, unexplained haematuria, lower back pain, bone pain, and weight loss.<ul><li>If suspected, refer the man using a suspected cancer pathway referral (for an appointment within 2 weeks). For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/urological-cancers-recognition-referral/\">Urological cancers - recognition and referral</a>.</li></ul></li><li>Urological infection — may present with pain when urinating, pelvic pain, loin pain, fever, and abnormal urine dipstick test findings.<ul><li>If suspected, confirm and manage accordingly. For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/prostatitis-acute/\">Prostatitis - acute</a>, <a class=\"topic-reference external-reference\" href=\"/topics/prostatitis-chronic/\">Prostatitis - chronic</a>, <a class=\"topic-reference external-reference\" href=\"/topics/pyelonephritis-acute/\">Pyelonephritis - acute</a>, <a class=\"topic-reference external-reference\" href=\"/topics/urethritis-male/\">Urethritis - male</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/urinary-tract-infection-lower-men/\">Urinary tract infection (lower) - men</a>.</li></ul></li><li>Sciatica — may present with weakness, numbness, or tingling in the leg, and can cause or aggravate LUTS.<ul><li>For information on the diagnosis and management of sciatica, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/sciatica-lumbar-radiculopathy/\">Sciatica (lumbar radiculopathy)</a>.</li></ul></li></ul></li><li><strong><a class=\"topic-reference internal-reference\" href=\"/topics/luts-in-men/diagnosis/investigations/\">Investigations</a> should be guided by the symptoms, history, and examination.</strong></li><li><strong>Offer men considering any <a class=\"topic-reference internal-reference\" href=\"/topics/luts-in-men/management/\">treatment</a> for LUTS an assessment of their baseline symptoms with a validated symptom score, </strong>such as the <a class=\"topic-reference internal-reference\" href=\"/topics/luts-in-men/diagnosis/assessment/#international-prostate-symptom-score-ipss\">International Prostate Symptom Score (IPSS)</a>, to allow assessment of subsequent symptom change. </li></ul><!-- end field 28880ac5-33cb-4d1d-9c5c-657caf3fa676 --><!-- end item 4e974f82-5fe9-4cab-a9a5-cbd242eb0c13 -->","topic":{"id":"fdcce69d-578e-5994-a7c2-84be40932dd8","topicId":"a7bf3f2d-1d9e-47c0-9dd3-26731c4d092b","topicName":"LUTS in men","slug":"luts-in-men","lastRevised":"Last revised in March 2019","chapters":[{"id":"149361eb-636f-59a5-a2e2-b067d629a065","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"c7972342-637c-56a9-8783-c1e8314e7fd1","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"7105be47-f38b-5335-b14d-69db43326579","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"c8165ab8-59af-557d-824d-58f09041698f","slug":"changes","fullItemName":"Changes"},{"id":"776566d2-009e-5ebd-ac21-e5605029213a","slug":"update","fullItemName":"Update"}]},{"id":"4c1332b1-3f4f-530f-bb70-d627804caa79","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d434ba09-30c6-5bfc-bb6f-87e952a1b33a","slug":"goals","fullItemName":"Goals"},{"id":"702b01d3-71e8-5daf-a985-3935596391f5","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"0aef110d-14b4-5ae2-9da0-a07cc4aef9ef","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7fcf6ae7-162e-5b90-84fb-2a79f82d420e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1c91c138-4e44-571e-8ac0-8e62f8dca310","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4fe99a13-4e80-5c28-b091-216c8a8d7f82","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"3a98397f-2bc4-5e01-90d6-03d6fbe400c8","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"d41a85e2-c1cb-5198-afc7-7c4fbe28ae24","slug":"definitions","fullItemName":"Definitions"},{"id":"fd0f4942-31d6-517a-a10b-d341e34a2504","slug":"causes-of-luts","fullItemName":"Causes of LUTS"},{"id":"3af3e2a4-26b3-5a77-9e8b-3d393388e624","slug":"prevalence","fullItemName":"Prevalence"},{"id":"1c6eecc6-b753-5918-adae-dc2d864d88fa","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"d1432aa0-7841-5eec-85c4-e344d4629bd9","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"762c13bd-ead4-5aa6-b460-701b0572f9aa","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"8874a841-31e1-5356-a3f6-7bff9c28c693","slug":"assessment","fullItemName":"Assessment"},{"id":"8c77fb91-6134-565b-b1ef-4452e83c424f","slug":"investigations","fullItemName":"Investigations"}]},{"id":"60ffa7b7-da40-599a-bffa-e6e68db76a97","fullItemName":"Management","slug":"management","subChapters":[{"id":"1d790431-a0c8-5ca1-8143-be639ea2ec02","slug":"voiding-symptoms","fullItemName":"Scenario: Voiding symptoms"},{"id":"b1451e1b-3776-5aa0-94b0-79be5fb01831","slug":"overactive-bladder","fullItemName":"Scenario: Overactive bladder"},{"id":"f4818005-dc3a-52b2-ac5d-d14f0d6ac0db","slug":"nocturnal-polyuria","fullItemName":"Scenario: Nocturnal polyuria"},{"id":"fb3acb54-4d76-5aad-ab1c-7b0b3d9443a3","slug":"stress-urinary-incontinence","fullItemName":"Scenario: Stress urinary incontinence"},{"id":"c511bb10-1198-548d-8e23-a1f6e98df926","slug":"urinary-retention","fullItemName":"Scenario: Urinary retention"},{"id":"0a3e83b8-a00f-520f-b21f-9ef6cc6440e7","slug":"post-micturition-dribble","fullItemName":"Scenario: Post-micturition dribble"}]},{"id":"40ed844e-b196-5a8a-9d88-2ff299e04d85","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"9c9f3458-4ae7-5003-a4f9-ed026a61a3d0","slug":"alpha-blockers","fullItemName":"Alpha-blockers"},{"id":"2f32bd76-64d1-51c9-bc96-4173829de1b5","slug":"5-alpha-reductase-inhibitors","fullItemName":"5-alpha reductase inhibitors"},{"id":"d7f3eec1-9124-5d3a-a793-15707f8cfeda","slug":"antimuscarinics","fullItemName":"Antimuscarinics"},{"id":"507e078b-b3d0-527c-b71d-0b1101948c01","slug":"mirabegron","fullItemName":"Mirabegron"},{"id":"7c2851da-6e40-5415-ada7-7466766510fa","slug":"furosemide","fullItemName":"Furosemide"},{"id":"ae12d520-87b4-5400-8cfa-79a25bb39663","slug":"desmopressin","fullItemName":"Desmopressin"}]},{"id":"dca797b5-427f-5ed5-94e4-3ad565f628a9","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5e289c42-8089-5739-9683-20c374967578","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"07accac1-c375-54a3-92cc-d2cd8a2bb914","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c05a5332-4c79-595e-b066-09dcd9841073","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"8e5cf2cc-d3d4-5d7d-82a7-3dd1ae3c65d9","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"47ea76bd-52d3-5c5a-8d1f-f574eec081bd","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"38a45d79-a74f-5ca9-a844-f16ea2c0ab75","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0b3152db-f873-5814-b35f-54711f247dff","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"762c13bd-ead4-5aa6-b460-701b0572f9aa","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"4834519e-1235-59eb-b41f-18e2862a80d1","slug":"urinary-frequency-volume-chart","fullItemName":"Urinary frequency-volume chart","depth":3,"htmlHeader":"<!-- begin field c7c8482c-235a-42f4-96de-bfb617ecfe5d --><h3>Urinary frequency-volume chart</h3><!-- end field c7c8482c-235a-42f4-96de-bfb617ecfe5d -->","summary":null,"htmlStringContent":"<!-- begin item decf8a72-ee49-4ff6-920a-f186ba8face0 --><!-- begin field 5414e77c-f535-4110-a0bc-e94da985179b --><ul><li><strong>A urinary frequency–volume chart is used to help distinguish and diagnose the following:</strong><ul><li>Frequency — high frequency with normal 24-hour volume suggests that the bladder capacity is diminished (the male bladder normally holds 300–600 mL urine comfortably).</li><li>Polyuria (passing more urine than usual) — up to 3 L of urine in 24 hours is normal.</li><li>Nocturia (waking at night to urinate).</li><li>Nocturnal polyuria (passing, at night, more than 35% of the 24-hour urine production).</li></ul></li><li>Urinary frequency–volume charts are freely available online, for example from the Bladder Matters website (<a data-hyperlink-id=\"f0deeb0c-49a8-49f2-8985-a93100a68779\" href=\"http://www.bladdermatters.co.uk/downloads/85923fchart.pdf\">www.bladdermatters.co.uk</a>).</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">National Clinical Guideline Centre, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">European Association of Urology, 2018</a>]</p><!-- end field 5414e77c-f535-4110-a0bc-e94da985179b --><!-- end item decf8a72-ee49-4ff6-920a-f186ba8face0 -->","subChapters":[]},{"id":"e93c8a06-f500-5859-b550-b045cdf37f3a","slug":"international-prostate-symptom-score-ipss","fullItemName":"International Prostate Symptom Score (IPSS)","depth":3,"htmlHeader":"<!-- begin field d7e2f699-1a63-4d82-997d-eafc98fa8adc --><h3>International Prostate Symptom Score (IPSS)</h3><!-- end field d7e2f699-1a63-4d82-997d-eafc98fa8adc -->","summary":null,"htmlStringContent":"<!-- begin item d96ededb-d786-4cce-9b42-072b4c0acdf5 --><!-- begin field 9cef300c-8e3c-4780-8573-baeed297e909 --><ul><li><strong>The International Prostate Symptom Score (IPSS) is a tool for classifying the severity of lower urinary tract symptoms (LUTS) and assessing the impact of LUTS on quality of life.</strong></li><li>The IPSS questionnaire is intended to be completed by the man. It contains seven questions relating to symptom severity (each question is scored from 0 [best] to 5 [worst]) and one question relating to quality of life due to urinary symptoms (scored from 0 [best] to 6 [worst]). <ul><li>The IPSS severity score is interpreted as:<ul><li>Score 20–35: severely symptomatic.</li><li>Score 8–19: moderately symptomatic.</li><li>Score 0–7: mildly symptomatic.</li></ul></li></ul></li><li>Limitations of the IPSS questionnaire include lack of assessment of incontinence, post-micturition symptoms, and bother caused by each separate symptom.</li><li>Printable versions of the IPSS questionnaire are widely available online, for example from the Royal United Hospital Bath NHS trust website (<a data-hyperlink-id=\"c008b56b-620c-4464-9c22-a93100a19505\" href=\"http://www.ruh.nhs.uk/patients/Urology/documents/patient_leaflets/Form_IPSS.pdf\">www.ruh.nhs.uk</a>).</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">National Clinical Guideline Centre, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">European Association of Urology, 2018</a>]</p><!-- end field 9cef300c-8e3c-4780-8573-baeed297e909 --><!-- end item d96ededb-d786-4cce-9b42-072b4c0acdf5 -->","subChapters":[]},{"id":"1aa4b7c3-1dcb-5aa8-aa97-bb7d18f24445","slug":"basis-for-recommendation-230","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 86dc68af-ff83-47c8-b6d8-6fd12d4671a2 --><h3>Basis for recommendation</h3><!-- end field 86dc68af-ff83-47c8-b6d8-6fd12d4671a2 -->","summary":null,"htmlStringContent":"<!-- begin item 230e8bf7-8584-40fb-995b-d5e25393fe2d --><!-- begin field 05e29fb2-7462-44ea-b2d6-95d1b00fcc94 --><p>These recommendations are based largely on the National Institute for Health and Clinical Excellence (NICE) guidelines <em>The management of lower urinary tract symptoms in men </em>(full NICE guideline) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">National Clinical Guideline Centre, 2015</a>] and <em>Lower urinary tract symptoms in men: management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">NICE, 2015</a>], and the European Association of Urology (EAU) guideline <em>Management of Non-neurogenic Male LUTS</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">European Association of Urology, 2018</a>].</p><h4>History and examination</h4><ul><li>Experts recommend a complete medical history and examination for men with lower urinary tract symptoms (LUTS) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">National Clinical Guideline Centre, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">European Association of Urology, 2018</a>].</li><li>According to NICE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">National Clinical Guideline Centre, 2015</a>]:<ul><li>Diagnosis of the underlying cause of LUTS in men is of paramount importance and is central to clinical treatment.</li><li>A differential diagnosis allows focused investigation and management before a firm diagnosis is reached and a management plan formulated.</li></ul></li><li>According to the EAU [<a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">European Association of Urology, 2018</a>]:<ul><li>The aim of a medical history is to identify the potential causes of LUTS as well as any relevant comorbidities the person may have. It also allows the clinician to review the person’s current medication and lifestyle habits.</li><li>Clinical assessment of people with LUTS will help identify the differential diagnoses, since the origin of male LUTS is multifactorial, and help define the clinical profile (including the risk of disease progression) of men with LUTS in order to provide appropriate management.</li></ul></li><li>The recommendation on digital rectal examination is based on the NICE guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">National Clinical Guideline Centre, 2015</a>] and the EAU guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">European Association of Urology, 2018</a>]. The EAU highlights that although digital rectal examination can be used to assess prostate volume, the correlation to actual prostate volume is poor.</li></ul><h4>Using a frequency-volume chart </h4><ul><li>NICE recommends that men with bothersome LUTS are asked to complete a urinary frequency-volume chart [<a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">National Clinical Guideline Centre, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">NICE, 2015</a>].<ul><li>This recommendation was based on the consensus opinion of the NICE guideline development group (GDG) as no clinical or economic evidence was found.</li><li>The GDG felt that the frequency-volume chart is a simple, non-invasive tool that can help build on information obtained from the medical history and help the clinician to make an accurate diagnosis of the underlying cause of the symptoms.</li><li>The GDG highlighted that completing the chart would be difficult or impossible for people who are blind, cannot read English, or have learning disabilities.</li></ul></li><li>The EAU strongly recommends the use of frequency-volume charts to assess men with LUTS, especially those with storage symptoms and/or nocturia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">European Association of Urology, 2018</a>]. Evidence identified by the EAU suggests that:<ul><li>Frequency-volume charts provide real-time documentation of urinary function and reduce recall bias.</li><li>Three- and seven-day frequency-volume charts provide a reliable measurement of urinary symptoms in people with LUTS.</li></ul></li></ul><h4>Using a validated symptom score, such as the International Prostate Symptom Score (IPSS)</h4><ul><li>NICE recommends that men who are considering any treatment for LUTS are offered an assessment of their baseline symptoms with a validated symptom score (such as the IPSS) to allow assessment of subsequent symptom change [<a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">National Clinical Guideline Centre, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">NICE, 2015</a>].<ul><li>This recommendation was based on the consensus opinion of the NICE GDG as no clinical or economic evidence was found.</li><li>The GDG felt that it was not essential for all men with LUTS to complete a symptom score because it is time consuming and does not add much to the medical history taking at initial assessment. However, it would be beneficial at the stage when men were considering treatment, as it would provide a baseline score to monitor their response to treatment.</li><li>The GDG also highlighted the fact that completing the symptom score questionnaire would be difficult or impossible for people who are blind, cannot read English, or have learning disabilities.</li></ul></li><li>The EAU strongly recommends that a validated symptom score questionnaire that includes bother and quality of life assessment is used during the assessment of men with LUTS and for re-evaluation during and/or after treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/luts-in-men/references/\">European Association of Urology, 2018</a>]. <ul><li>Evidence identified by the EAU suggests that symptom questionnaires are sensitive to symptom changes and that symptom scores can quantify LUTS and identify which types of symptoms are predominant; however, they are not disease- or age-specific.</li></ul></li></ul><!-- end field 05e29fb2-7462-44ea-b2d6-95d1b00fcc94 --><!-- end item 230e8bf7-8584-40fb-995b-d5e25393fe2d -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}